There's no other word they can legally use unless they want to give the approval on the spot. That's standard language for 'we agree it is sufficient' . They have been in negotiations for 3.5 years. They are familiar with the issues and have been clear what they needed. Mesoblast have met their acceptance criteria with regards to clinical evidence.There maybe another issue we don't know of that still requires more evidence but it isn't clinical data.
Mesoblast stock(rock)-take March 2024, page-30
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |